Johnson & Johnson shares gain the most in two months on Tuesday as second-quarter profit tops expectations, 2017 earnings forecast revised up
July 19, 2017 12:12 pm
Johnson & Johnsons (JNJ) second-quarter earnings exceeded market expectations, supported by strong demand for the newer additions to the companys product range, such as the Darzalex cancer drug. J&J also revised up its full-year earnings forecast. Johnson & Johnson shares closed higher for a third time in the past seven trading sessions on Tuesday. It […] Read more